NSJ Bioreagents
SKU(재고 관리 코드):V5937-100UG
LGALS9 Antibody / Galectin 9, 100ug
LGALS9 Antibody / Galectin 9, 100ug
가격·납기 및 기술자료를 확인해 드립니다.
제품 규격과 수량을 선택한 후 견적을 요청해 주세요. 대체품 검토와 SDS·COA·데이터시트 요청도 함께 접수할 수 있습니다.
이 제품 견적 요청대표번호 070-8028-3500 · info@rndmate.com
LGALS9 Antibody recognizes Galectin 9, also known as Lectin galactoside-binding soluble 9, a beta-galactoside-binding lectin encoded by the LGALS9 gene. Galectin 9 antibody is widely referenced in immunology literature as LGALS9 antibody and Gal-9 antibody due to its established role in immune regulation and tumor immunology. Galectin 9 belongs to the galectin family of carbohydrate-binding proteins characterized by conserved carbohydrate recognition domains that bind beta-galactoside-containing glycoconjugates.<br><br>Galectin 9 is expressed in a variety of immune and epithelial cell types and can localize to the cytoplasm, nucleus, and extracellular space depending on cellular context. Structurally, Galectin 9 contains two tandem carbohydrate recognition domains connected by a linker peptide, allowing it to crosslink glycoproteins on the cell surface. This structural organization enables Galectin 9 to modulate cell adhesion, apoptosis, and immune checkpoint signaling pathways. LGALS9 antibody is commonly used in studies evaluating Galectin 9 expression in inflammatory diseases, viral infections, and cancer microenvironments.<br><br>Functionally, Galectin 9 is best known for its interaction with immune regulatory receptors such as TIM-3, influencing T cell exhaustion, tolerance, and immune homeostasis. Through these interactions, Galectin 9 participates in the regulation of innate and adaptive immune responses. Altered expression of LGALS9 has been reported in multiple tumor types, where Galectin 9 expression may correlate with immune infiltration and tumor immune evasion mechanisms. As a result, Galectin 9 antibody is frequently utilized in tumor immunology and biomarker research settings.<br><br>Beyond immune modulation, Galectin 9 has been implicated in cell aggregation, apoptosis induction, and regulation of cytokine production. Differential expression patterns across tissues and disease states make LGALS9 Antibody a valuable tool for examining Galectin 9 distribution and its role in immune checkpoint biology, inflammatory signaling, and cancer-associated immune landscapes.
Specifications
| Catalog No | V5937-100UG |
|---|---|
| Family | Primary antibody |
| Qty | 100ug |
| Formulation | 0.2 mg/ml in 1X PBS with 0.05% BSA, 0.05% sodium azide |
| Format | Purified |
| Clone | LGALS9/7689 |
| Host Animal | Mouse |
| Clonality | Monoclonal (mouse origin) |
| Isotype | Mouse IgG2, kappa |
| Species Reactivity | Human |
| Application | IHC |
| Application Details | Immunohistochemistry (FFPE): 1-2ug/ml |
| Application Note | Optimal dilution of the LGALS9/Galectin 9 antibody should be determined by the researcher. |
| Status | Available |
| PDF Link | Product Data Sheet (PDF) |
| Limitation | This LGALS9/Galectin 9 antibody is available for research use only. |
| Uniprot # | O00182 |
| Immunogen | A recombinant fragment (around amino acids 200-355) of human LGALS9 protein (exact sequence is proprietary) was used as the immunogen for the LGALS9/Galectin 9 antibody. |
| Storage | LGALS9/Galectin 9 antibody with sodium azide - store at 2 to 8oC; antibody without sodium azide - store at -20 to -80oC. |
| Localization | Cytoplasm |
| Title | LGALS9 Antibody / Galectin 9 |